Found 17 clinical trials
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of …
- 0 views
- 19 Feb, 2024
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
The evidence on the value of aspirin, statins, metformin, beta-blocking ACE inhibitors agents as chemopreventive agents in patients with pancreatic ductal adenocarcinoma is limited. The aim of this study is to assess whether regular use of aspirin, statins, metformin, angiotensin converting enzyme (ACE)-inhibitors and beta-blocking agents use, before diagnosis, after …
- 0 views
- 19 Feb, 2024
UCSF Panc Cyst Registry
Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to …
- 0 views
- 19 Feb, 2024
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
This is a Norwegian prospective observational study that evaluates the resectability rate in patients with borderline resectable and locally advanced pancreatic cancer who received neoadjuvant chemotherapy in a population based cohort. Eligible patients are treated with neoadjuvant chemotherapy possibly followed by surgical exploration and resection.
- 0 views
- 19 Feb, 2024
A Longitudinal Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
Based on the literature, the pancreatic cancer treatment predictor biomarker, which is used in the domestic clinical field, is actually applied to the pancreatic cancer patient cohort of the National Cancer Center.
- 0 views
- 19 Feb, 2024
The Role of MicroRNA in the Diagnosis Prognosis and Response to Treatment in Pancreatic Cancer
We hypothesize that the detection of certain miRNAs present in the blood/serum of patients with pancreatic cancer may be important to the early diagnosis of the disease. Furthermore, we hypothesize that miRNA detection in PC patients will yield prognostic information and help predict the response to treatment.
- 0 views
- 19 Feb, 2024
Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors
A special focus is made on quality of life and psycho-social impact of treatment modifications on patients diagnosed with metastatic colorectal cancer and metastatic pancreatic cancer.
- 0 views
- 19 Feb, 2024
- 1
- 2